Nova Science, developed and patented a disposable closure device to seal arteries after cardiac surgery.

Nova Science was acquired by Abbot Laboratories (NYSE: ABT).

ACT Venture Capital co-led the Series B investment in Nova Science with co-investors Trinity Venture Capital and MVM Life Sciences Partners.